Add Company
Join Now

DEM Biopharma Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • DEM Biopharma's estimated annual revenue is currently $3.5M per year.(i)
  • DEM Biopharma's estimated revenue per employee is $77,500

Employee Data

  • DEM Biopharma has 45 Employees.(i)
  • DEM Biopharma grew their employee count by 67% last year.

DEM Biopharma's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is DEM Biopharma?

DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is supported by a syndicate of biotech investors and headquartered in Boston, MA.

keywords:N/A

N/A

Total Funding

45

Number of Employees

$3.5M

Revenue (est)

67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27M45-62%$281.5M
#2
$7.6M45-6%$128.2M
#3
$3.5M4518%N/A
#4
$12.7M45-18%N/A
#5
$3.7M4518%N/A